This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Mandadapu Raghuramaiah: Innovator in Phosphodiesterase Inhibitors
Introduction
Mandadapu Raghuramaiah is a notable inventor based in Guntur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors.
Latest Patents
Raghuramaiah holds a patent for "Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors." This invention relates to phosphodiesterase (PDE) type IV selective inhibitors. The patent outlines processes for the preparation of the disclosed compounds, pharmaceutical compositions containing these compounds, and their use as PDE type IV selective inhibitors. The prepared compounds correspond to structure XIV Formula (XIV). He has 1 patent to his name.
Career Highlights
Raghuramaiah is associated with Ranbaxy Laboratories, Inc., where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the understanding and application of phosphodiesterase inhibitors in medical treatments.
Collaborations
He has collaborated with notable colleagues such as Vinayak Vasantrao Khairnar and Abhijit Ray, enhancing the innovative efforts within his team.
Conclusion
Mandadapu Raghuramaiah's contributions to the field of pharmaceuticals, particularly through his patent on phosphodiesterase inhibitors, highlight his role as an influential inventor. His work continues to impact the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile